
In the second part of our interview, Novartis's Martina Lioi talks about using IP-HILIC and RP for lipid-siRNA impurities
Click the title above to open the LCGC North America July 2019 issue, Volume 37, Number 7, in an interactive PDF format.
over 7 years ago
Environmental Method Development: Key Challenges and Unmet Needsover 7 years ago
Temperature Programmed GC: Why Are All Those Peaks So Sharp?over 7 years ago
Electron Capture Detectors





